USPSTF Exact Sciences Stock Falls on Publication of New CRC Screening Cost-Effectiveness Study The study said that Cologuard was an "inefficient screening option" for colorectal cancer given its cost as compared to other CRC screening methods. Slightly Larger Pool New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times. USPSTF Formalizes Slightly Expanded BRCA Screening Recommendations After reviewing more than 100 studies, the panel issued recommendations focused on women with a personal or family history of BRCA1/2-related cancers or high-risk ancestry. Back for Another Round The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight. BRCA Screening Guidelines Too Reliant on Family History, Stakeholders Tell USPSTF Premium By focusing too heavily on family history, the Preventive Services Task Force is missing many opportunities for prevention, patient advocates, industry players, and researchers say. May 30, 2018 Exact Sciences Shares Rise Sharply on New Colorectal Cancer Screening Recommendation Sep 12, 2017 USPSTF Draft Cervical Cancer Screening Guidelines Could Bring Headwinds for Pap Test Providers Oct 26, 2016 USPSTF Guidelines May Have Used Old Data on Epigenomics Colorectal Cancer Screening Test Aug 11, 2016 Genetic Tests Reveal Role for Preventive Care, but Insurance Doesn't Always Cover Jul 26, 2016 Exact Sciences Revenues More Than Double on Cologuard Sales Jul 5, 2016 Exact Sciences, GenMark Diagnostics Stand Out in June GWDN Index as Brexit Fears Push Stocks Down Jun 15, 2016 New Colorectal Cancer Screening Guidelines From USPSTF May Benefit Exact Sciences' Cologuard Oct 26, 2015 UC Launches Framingham-Like Study to Inform Personalized Breast Cancer Screening Guidelines Premium Oct 6, 2015 Exact Planning to Work With USPSTF to Change Recommendation on Cologuard Breaking News Analysis Finds Sibling Cascade Testing Could Be Cost Effective in Pediatric Cancer Armonica Technologies Closes $2M Series B Financing Round Top Five Articles on GenomeWeb Last Week: SARS-CoV-2 PCR Tests; California Cancer Testing Law; More In Brief This Week: The Jackson Laboratory, CareDx, Merck Global Health Innovation Fund, and More People in the News: New Appointments at Grail, Foundation Medicine, Personalis, More New Products Posted to GenomeWeb: NanoString, Sophia Genetics, EliTech, Lybe Scientific, More The Scan J&J Booster Support A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times. To Keep the Cases Moving The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases. NAS Expels Archaeologist Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences. PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.